Home / Market News / $MPW
fiscal.ai Corporate Catalyst Impact 65/100 ● negative

BNP Paribas Downgrades Medical Properties Trust to Neutral

Nov 3, 2026, 2:05 PM UTC · Primary ticker $MPW

BNP Paribas downgraded Medical Properties Trust (MPW) from Outperform to Neutral, setting a $2.25 price target. This downgrade reflects ongoing concerns about tenant issues and liquidity, following the company's Q3 2026 earnings report.

BNP Paribas has downgraded Medical Properties Trust (MPW) from Outperform to Neutral, assigning a new price target of $2.25. This action stems from persistent concerns regarding MPW's tenant issues and overall liquidity, which were likely exacerbated by their recent third-quarter 2026 earnings report. This downgrade signals a more cautious outlook from a major financial institution, potentially leading to negative short-term price pressure on MPW shares as investors react to the reduced rating and lower price target. For traders, this highlights increased downside risk for MPW, while long-term investors may view this as a re-evaluation of the company's fundamental challenges.

$MPW negative Analyst downgrade and price target reduction
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.